Ocular Biometrics in a French Population

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04992403
Collaborator
(none)
11,650
1
6.2
1866.3

Study Details

Study Description

Brief Summary

The investigators aimed to study ocular biometrics parameters and their association with age, gender and the prevalence of high myopia in a population of cataract surgery candidates in the South of France. The investigators also aimed to define proportion of an "usual eye" and know the rate of inhomogeneous eyes in our population.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    11650 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Ocular Biometric Measurements in Cataract Surgery Candidates in The South of France : a Multicenter Cross Sectional Study
    Actual Study Start Date :
    Jan 1, 2021
    Actual Primary Completion Date :
    Jul 1, 2021
    Actual Study Completion Date :
    Jul 10, 2021

    Outcome Measures

    Primary Outcome Measures

    1. number of patients with Distribution of ocular biometrics [1 day]

      Distribution of ocular biometrics and their association with age and gender

    Secondary Outcome Measures

    1. number of patients with Prevalence of high myopia [1 day]

      Prevalence of high myopia

    2. rate of inhomogeneous eyes [1 day]

      rate of inhomogeneous eyes

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • aged 40 years

    • olderpatients who underwent ocular biometrics before cataract surgery

    Exclusion criteria: incomplete examination

    • previous cataract surgery

    • age < 40 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UH Montpellier Montpellier France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier

    Investigators

    • Study Director: Vincent DAIEN, MD, PhD, HDR, University Hospitals of Montpellier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT04992403
    Other Study ID Numbers:
    • RECHMPL21_0458
    First Posted:
    Aug 5, 2021
    Last Update Posted:
    Aug 5, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Montpellier
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 5, 2021